Pons G - Search Results

1

Influence of stiripentol on cytochrome P450-mediated metabolic pathways in humans: in vitro and in vivo comparison and calculation of in vivo inhibition constants.

Tran A, Rey E, Pons G, Rousseau M, d'Athis P, Olive G, Mather GG, Bishop FE, Wurden CJ, Labroo R, Trager WF, Kunze KL, Thummel KE, Vincent JC, Gillardin JM, Lepage F, Levy RH. Tran A, et al. Among authors: pons g. Clin Pharmacol Ther. 1997 Nov;62(5):490-504. doi: 10.1016/S0009-9236(97)90044-8. Clin Pharmacol Ther. 1997. PMID: 9390105

2

In vitro and in vivo inhibitory effect of stiripentol on clobazam metabolism.

Giraud C, Treluyer JM, Rey E, Chiron C, Vincent J, Pons G, Tran A. Giraud C, et al. Among authors: pons g. Drug Metab Dispos. 2006 Apr;34(4):608-11. doi: 10.1124/dmd.105.007237. Epub 2006 Jan 13. Drug Metab Dispos. 2006. PMID: 16415114

3

A simple non-invasive procedure for the investigation of cytochrome P-450 IIIA dependent enzymes in humans.

Bienvenu T, Rey E, Pons G, d'Athis P, Olive G. Bienvenu T, et al. Among authors: pons g. Int J Clin Pharmacol Ther Toxicol. 1991 Nov;29(11):441-5. Int J Clin Pharmacol Ther Toxicol. 1991. PMID: 1800391

4

Maturation of caffeine metabolic pathways in infancy.

Carrier O, Pons G, Rey E, Richard MO, Moran C, Badoual J, Olive G. Carrier O, et al. Among authors: pons g. Clin Pharmacol Ther. 1988 Aug;44(2):145-51. doi: 10.1038/clpt.1988.129. Clin Pharmacol Ther. 1988. PMID: 3396261

5

Metoclopramide plasma concentration in neonates.

Vauzelle-Kervroedan F, Rey E, D'Athis P, Badoual J, Olive G, Pons G. Vauzelle-Kervroedan F, et al. Among authors: pons g. Int J Clin Pharmacol Ther. 1997 Nov;35(11):519-21. Int J Clin Pharmacol Ther. 1997. PMID: 9401834 Clinical Trial.

6

Protective effect of stiripentol on acetaminophen-induced hepatotoxicity in rat.

Tran A, Tréluyer JM, Rey E, Barbet J, Ferracci G, d'Athis P, Vincent J, Pons G. Tran A, et al. Among authors: pons g. Toxicol Appl Pharmacol. 2001 Feb 1;170(3):145-52. doi: 10.1006/taap.2000.9091. Toxicol Appl Pharmacol. 2001. PMID: 11162779

7

Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human.

Cazali N, Tran A, Treluyer JM, Rey E, d'Athis P, Vincent J, Pons G. Cazali N, et al. Among authors: pons g. Br J Clin Pharmacol. 2003 Nov;56(5):526-36. doi: 10.1046/j.0306-5251.2003.01919.x. Br J Clin Pharmacol. 2003. PMID: 14651727 Free PMC article.

8

In vitro characterization of clobazam metabolism by recombinant cytochrome P450 enzymes: importance of CYP2C19.

Giraud C, Tran A, Rey E, Vincent J, Tréluyer JM, Pons G. Giraud C, et al. Among authors: pons g. Drug Metab Dispos. 2004 Nov;32(11):1279-86. Drug Metab Dispos. 2004. PMID: 15483195

9

Pharmacokinetic-pharmacodynamic study of oral lansoprazole in children.

Tran A, Rey E, Pons G, Pariente-Khayat A, D'Athis P, Sallerin V, Dupont C. Tran A, et al. Among authors: pons g. Clin Pharmacol Ther. 2002 May;71(5):359-67. doi: 10.1067/mcp.2002.122472. Clin Pharmacol Ther. 2002. PMID: 12011821

10

Vigabatrin. Clinical pharmacokinetics.

Rey E, Pons G, Olive G. Rey E, et al. Among authors: pons g. Clin Pharmacokinet. 1992 Oct;23(4):267-78. doi: 10.2165/00003088-199223040-00003. Clin Pharmacokinet. 1992. PMID: 1395360 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

362 results

Search Page